Life Sciences Clusters in Europe

What makes a European Life Science site attractive to foreign investors? Together with KPMG Switzerland Venture Valuation has published this second edition statistic and extensive numbers on the European Biotechnology, Medical Technology and Pharma environment. The data is based on Biotechgate, the global Life Sciences database. Site Selection for Life Sciences Companies in Europe 2015: … Continue reading Life Sciences Clusters in Europe

Read more

Life Science Trend Analysis 2015 for France

Venture financing of French biotech companies is setting out to be very strong in the second half of this year, as it has already surpassed the levels seen in the second half of 2013 and 2014 respectively. France LS Trend Analysis 2015

Read more

Webinar on clinical trials for Horizon 2020 projects

This miniclip, organized by Fit for Health 2.0 (http://www.fitforhealth.eu/), presents definitions and resources for registration and design of clinical trials in the EU. The presentation includes an introduction to the procedure to get clinical trials funded in Horizon 2020. Mini-Clip PDF Presentation, 11, 464kB Mini-Clip

Read more

MedTech Investment Landscape

Even though the number of medical technology companies in North America, Europe and Asia are not so different, the investment landscape is very much so. See the actual numbers in a recent presentation of Venture Valuation in Singapore. Medtech Connect, Singapore, July 2014, 9 pages, 512kb

Read more